Determination of fetal chromosome aberrations from fetal DNA in maternal blood: Has the challenge finally been met?

Expert Reviews in Molecular Medicine

Volumn 13, Issue , 2011, Pages

  Hahn, Sinuhe ^a   Lapaire, Olav ^a   Tercanli, Sevgi ^a   Kolla, Varaprasad ^a   Hösli, Irene ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MASPIN; NUCLEIC ACID; PLACENTA PROTEIN; PLACENTA PROTEIN 4; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; CELL FREE SYSTEM; CELL ISOLATION; CHROMOSOME 21; CHROMOSOME ABERRATION; DNA DETERMINATION; DOWN SYNDROME; EPIGENETICS; EXTRACHROMOSOMAL INHERITANCE; FETUS; FETUS CELL; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MATERNAL BLOOD; NEXT GENERATION SEQUENCING; NON INVASIVE MEASUREMENT; NUCLEIC ACID ANALYSIS; PATAU SYNDROME; POINT MUTATION; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRISOMY 18; TRISOMY 21; FEMALE; HIGH THROUGHPUT SEQUENCING; METABOLISM; PREGNANCY; REVIEW;

CHROMOSOME ABERRATIONS; DNA; FEMALE; FETUS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 79956088338     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399411001852     Document Type: Article

References (78)

1. Hahn, S., Jackson, L.G. and Zimmermann, B.G. (2010) Prenatal diagnosis of fetal aneuploidies: post-genomic developments. Genome Medicine 2, 50
2. Bianchi, D.W. (2010) From Michael to microarrays: 30 years of studying fetal cells and nucleic acids in maternal blood. Prenatal Diagnosis 30, 622-623
3. Ferguson-Smith, M.A. and Bianchi, D.W. (2010) Prenatal diagnosis: past, present, and future. Prenatal Diagnosis 30, 601-604
4. Lo, Y.M. (2010) Noninvasive prenatal diagnosis in 2020. Prenatal Diagnosis 30, 702-703
5. Morris, J.K. and Alberman, E. (2009) Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register. British Medical Journal 339, b3794
6. Philip, J. et al. (2004) Late first-trimester invasive prenatal diagnosis: results of an international randomized trial. Obstetrics and Gynecology 103, 1164-1173 (Pubitemid 40458945)
7. Chiu, R.W. et al. (2011) Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. British Medical Journal 342, c7401
8. Jackson, L. and Pyeritz, R.E. (2011) Molecular technologies open newclinical genetic vistas. Science Translational Medicine 3, 65-62
9. Lo, Y.M. et al. (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350, 485-487 (Pubitemid 27343304)
10. van der Schoot, C.E., Hahn, S. and Chitty, L.S. (2008) Non-invasive prenatal diagnosis and determination of fetal Rh status. Seminars in Fetal and Neonatal Medicine 13, 63-68
11. Chitty, L.S. et al. (2008) SAFE-the special noninvasive advances in fetal and neonatal evaluation network: aims and achievements. Prenatal Diagnosis 28, 83-88 (Pubitemid 351311147)
12. Finning, K. et al. (2008) Effect of high throughput RHD typing of fetalDNAin maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. British Medical Journal 336, 816-818 (Pubitemid 351548224)
13. Gautier, E. et al. (2005) Fetal RhD genotyping by maternal serum analysis: a two-year experience. American Journal of Obstetrics and Gynecology 192, 666-669 (Pubitemid 40311254)
14. Maddocks, D.G. et al. (2009) The SAFE project: towards non-invasive prenatal diagnosis. Biochemical Society Transactions 37, 460-465
15. Lo, Y.M. (2009) Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art. British Journal of Obstetrics and Gynecology 116, 152-157
16. Krentz, S.E. and Pilskaln, S.M. (1988) Product life cycle: still a valid framework for business planning. Top Health Care Finance 15, 40-48
17. Lo, Y.M. et al. (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. American Journal of Human Genetics 62, 768-775 (Pubitemid 28194317)
18. Zimmermann, B. et al. (2005) Optimized real-time quantitative PCR measurement of male fetalDNAin maternal plasma. Clinical Chemistry 51, 1598-1604 (Pubitemid 41233093)
19. Sikora, A. et al. (2010) Detection of increased amounts of cell-free fetal DNA with short PCR amplicons. Clinical Chemistry 56, 136-138
20. Chan, K.C. et al. (2004) Size distributions of maternal and fetal DNA in maternal plasma. Clinical Chemistry 50, 88-92 (Pubitemid 38125703)
21. Li, Y. et al. (2004) Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clinical Chemistry 50, 1002-1011 (Pubitemid 38725787)
22. Hahn, S. and Zimmermann, B.G. (2010) Cell-free DNA in maternal plasma: has the size-distribution puzzle been solved? Clinical Chemistry 56, 1210-1211
23. Fan, H.C. et al. (2010) Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing. Clinical Chemistry 56, 1279-1286
24. Lo, Y.M. et al. (2010) Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Science Translational Medicine 2, 61ra91
25. Li, Y. et al. (2005) Detection of paternally inherited fetal point mutations for beta-thalassemia using sizefractionated cell-free DNA in maternal plasma. Journal of the American Medical Association 293, 843-849 (Pubitemid 40250368)
26. Li, Y. et al. (2004) Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma - case report. Prenatal Diagnosis 24, 896-898 (Pubitemid 39576805)
27. Li, Y. et al. (2007) Non-invasive prenatal detection of achondroplasia in size-fractionated cell-freeDNAby MALDI-TOFMS assay. Prenatal Diagnosis 27, 11-17 (Pubitemid 46144334)
28. Li, Y. et al. (2006) Genotyping fetal paternally inherited SNPs by MALDI-TOF MS using cell-free fetal DNA in maternal plasma: influence of size fractionation. Electrophoresis 27, 3889-3896 (Pubitemid 44608408)
29. Flori, E. et al. (2004) Circulating cell-free fetalDNAin maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report. Human Reproduction 19, 723-724 (Pubitemid 38344540)
30. Alberry, M. et al. (2007) Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenatal Diagnosis 27, 415-418 (Pubitemid 47164339)
31. Chim, S.S. et al. (2008) Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clinical Chemistry 54, 500-511 (Pubitemid 351348156)
32. Chim, S.S. et al. (2005) Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proceedings of the National Academy of Sciences of the United States of America 102, 14753-14758 (Pubitemid 41457128)
33. Chiu, R.W. et al. (2007) Hypermethylation of RASSF1A in human and rhesus placentas. American Journal of Pathology 170, 941-950 (Pubitemid 47339363)
34. Ehrich, M. et al. (2011) Noninvasive detection of fetal trisomy 21 by sequencing ofDNAin maternal blood: a study in a clinical setting. American Journal of Obstetrics and Gynecology 204, 205.e1-205.e11
35. Lo, Y.M. et al. (2007) Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nature Medicine 13, 218-223
36. Gandhi, S.J. et al. (2010) Transcription of functionally related constitutive genes is not coordinated. Nature Structural and Molecular Biology 18, 27-34
37. Lionnet, T. and Singer, R.H. (2010) Transcription, one allele at a time. Genome Biology 11, 129
38. Tong, Y.K. et al. (2006) Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations. Clinical Chemistry 52, 2194-2202 (Pubitemid 44924992)
39. Tong, Y.K. et al. (2010) Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clinical Chemistry 56, 90-98
40. Tsui, D.W. et al. (2010) Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards Syndrome. PLoS One 5, e15069
41. Papageorgiou, E.A. (2011) Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nature Medicine, Mar 6; [Epub ahead of print].
42. Papageorgiou, E.A. et al. (2009) Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. American Journal of Pathology 174, 1609-1618
43. Zimmermann, B. et al. (2007) Real-time quantitative polymerase chain reaction measurement of male fetal DNA in maternal plasma. Methods in Molecular Medicine 132, 43-49
44. Zimmermann, B. et al. (2006) Use of real-time polymerase chain reaction for the detection of fetal aneuploidies. Methods in Molecular Biology 336, 83-100
45. Vogelstein, B. and Kinzler, K.W. (1999) Digital PCR. Proceedings of the National Academy of Sciences of the United States of America 96, 9236-9241 (Pubitemid 29374738)
46. Zimmermann, B.G. et al. (2008) Digital PCR: a powerful new tool for noninvasive prenatal diagnosis? Prenatal Diagnosis 28, 1087-1093
47. Fan, H.C. and Quake, S.R. (2007) Detection of aneuploidy with digital polymerase chain reaction. Analytical Chemistry 79, 7576-7579 (Pubitemid 47606128)
48. Fan, H.C. et al. (2009) Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy. American Journal of Obstetrics and Gynecology 200, 543, e541-547
49. Lo, Y.M. et al. (2007) Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proceedings of the National Academy of Sciences of the United States of America 104, 13116-13121 (Pubitemid 351737602)
50. Ansorge, W.J. (2009) Next-generation DNA sequencing techniques. New Biotechnology 25, 195-203
51. Jones, S. et al. (2008) Comparative lesion sequencing provides insights into tumor evolution. Proceedings of the National Academy of Sciences of the United States of America 105, 4283-4288 (Pubitemid 351754372)
52. Leary, R.J. et al. (2010) Development of personalized tumor biomarkers using massively parallel sequencing. Science Translational Medicine 2, 20ra14
53. Chiu, R.W. et al. (2008) Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proceedings of the National Academy of Sciences of the United States of America 105, 20458-20463
54. Chiu, R.W., Cantor, C.R. and Lo, Y.M. (2009) Noninvasive prenatal diagnosis by single molecule counting technologies. Trends in Genetics 25, 324-331
55. Fan, H.C. et al. (2008) Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proceedings of the National Academy of Sciences of the United States of America 105, 16266-16271
56. Lo, Y.M. and Chiu, R.W. (2009) Next-generation sequencing of plasma/serum DNA: an emerging research and molecular diagnostic tool. Clinical Chemistry 55, 607-608
57. Liao, G.J. et al. (2010) Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles. Clinical Chemistry 57, 92-101
58. Szczepura, A., Osipenko, L. and Freeman, K. (2011) A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales. BMC Pregnancy and Childbirth 11, 5
59. Hahn, S. et al. (2009) Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies. Expert Review of Molecular Diagnostics 9, 613-621
60. Daniels, G., Finning, K. and Martin, P. (2010) Noninvasive fetal blood grouping: present and future. Clinics in Laboratory Medicine 30, 431-442
61. Ntouroupi, T.G. et al. (2008) Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope. British Journal of Cancer 99, 789-795
62. Seppo, A. et al. (2008) Detection of circulating fetal cells utilizing automated microscopy: potential for noninvasive prenatal diagnosis of chromosomal aneuploidies. Prenatal Diagnosis 28, 815-821
63. Lee, D. et al. (2010) Separation of model mixtures of epsilon-globin positive fetal nucleated red blood cells and anucleate erythrocytes using a microfluidic device. Journal ofChromatographyA1217, 1862-1866
64. Huang, R. et al. (2008) A microfluidics approach for the isolation of nucleated red blood cells (NRBCs) from the peripheral blood of pregnant women. Prenatal Diagnosis 28, 892-899
65. Evans, M.I. et al. (2006) Automated microscopy of amniotic fluid cells: detection of FISH signals using the FastFISH imaging system. Fetal Diagnosis and Therapy 21, 523-527 (Pubitemid 44804592)
66. Wells, D. (2010) Embryo aneuploidy and the role of morphological and genetic screening. Reproductive Biomedicine Online 21, 274-277
67. Avgidou, K. et al. (2005) Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies. American Journal of Obstetrics and Gynecology 192, 1761-1767 (Pubitemid 40827043)
68. Falcon, O. et al. (2006) Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11+ 0 to 13+ 6weeks. Ultrasound in Obstetrics and Gynecology 27, 151-155 (Pubitemid 43733729)
69. Cowans, N.J. et al. (2009) The impact of fetal gender on first trimester nuchal translucency and maternal serum free beta-hCG and PAPP-A MoM in normal and trisomy 21 pregnancies. Prenatal Diagnosis 29, 578-581
70. Spencer, K. et al. (2001) Maternal serum levels of dimeric inhibin A in pregnancies affected by trisomy 21 in the first trimester. PrenatalDiagnosis 21, 441-444 (Pubitemid 32666613)
71. Spencer,K. et al. (2001) Maternal serum levels of total activin-A in first-trimester trisomy 21 pregnancies. Prenatal Diagnosis 21, 270-273 (Pubitemid 32417210)
72. Schmidt, A. and Aebersold, R. (2006) High-accuracy proteome maps of human body fluids. Genome Biology 7, 242
73. Choolani, M. et al. (2009) Proteomic technologies for prenatal diagnostics: advances and challenges ahead. Expert Review of Proteomics 6, 87-101
74. Kolla, V. et al. (2010) Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ). Journal of Biomedicine and Biotechnology 2010, 952047
75. Kolialexi, A. et al. (2008) Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma. Prenatal Diagnosis 28, 691-698
76. Tsangaris, G.T. et al. (2006) Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics 6, 4410-4419 (Pubitemid 44277042)
77. Lopez, M.F. et al. (2010) Mass spectrometric discoveryand selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester trisomy 21 maternal serum. Journal of Proteome Research 10, 133-142
78. Nagalla, S.R. et al. (2007) Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers. Journal of Proteome Research 6, 1245-1257 (Pubitemid 46724021)